Please use this identifier to cite or link to this item:
https://dipositint.ub.edu/dspace/handle/2445/208111
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Coderch Negra, Ma. Luisa | - |
dc.contributor.author | Alonso, Cristina | - |
dc.contributor.author | Calpena Campmany, Ana Cristina | - |
dc.contributor.author | Pérez García, M. Lluïsa (Maria Lluïsa) | - |
dc.contributor.author | Clares Naveros, Beatriz | - |
dc.contributor.author | Ramos, Anderson | - |
dc.contributor.author | Martí, Meritxell | - |
dc.date.accessioned | 2024-02-27T12:14:25Z | - |
dc.date.available | 2024-02-27T12:14:25Z | - |
dc.date.issued | 2023-11-29 | - |
dc.identifier.issn | 1999-4923 | - |
dc.identifier.uri | https://hdl.handle.net/2445/208111 | - |
dc.description.abstract | <p>The permeability of the oral or nasal mucosa is higher than that of the skin. Mucosa permeability</p><p>depends mainly on the thickness and keratinization degree of the tissues. Their permeability</p><p>barrier is conditioned by the presence of certain lipids. This work has the main aim of reinforcing the</p><p>barrier effect of oral mucosa with a series of formulations to reduce permeation. Transmembrane</p><p>water loss of different formulations was evaluated, and three of them were selected to be tested on</p><p>the sublingual mucosa permeation of drugs. Caffeine, ibuprofen, dexamethasone, and ivermectin</p><p>were applied on porcine skin, mucosa, and modified mucosa in order to compare the effectiveness of</p><p>the formulations. A similar permeation profile was obtained in the different membranes: caffeine</p><p>> ibuprofen~dexamethasone > ivermectin. The most efficient formulation was a liposomal formulation</p><p>composed of lipids that are present in the skin stratum corneum. Impermeability provided</p><p>by this formulation was notable mainly for the low-molecular-weight compounds, decreasing their</p><p>permeability coefficient by between 40 and 80%. The reinforcement of the barrier function of mucosa</p><p>provides a reduction or prevention of the permeation of different actives, which could be extrapolated</p><p>to toxic compounds such as viruses, contaminants, toxins, etc.</p> | - |
dc.format.extent | 1 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/https://doi.org/10.3390/pharmaceutics15122698 | - |
dc.relation.ispartof | Pharmaceutics, 2023, vol. 15, p. 2698 | - |
dc.relation.uri | https://doi.org/https://doi.org/10.3390/pharmaceutics15122698 | - |
dc.rights | cc-by (c) Coderch, L. et al., 2023 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | - |
dc.source | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) | - |
dc.subject.classification | Membrana mucosa | - |
dc.subject.classification | Mucosa gastrointestinal | - |
dc.subject.other | Mucous membrane | - |
dc.subject.other | Gastrointestinal mucosa | - |
dc.title | Permeation Protection by Waterproofing Mucosal Membranes | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 740787 | - |
dc.date.updated | 2024-02-27T12:14:25Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
Appears in Collections: | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
836630.pdf | 2.77 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License